On-site hydrogen: what’s the big deal?

 

For years, one of the issues with hydrogen has been that it is manufactured at one facility – sometimes as a byproduct – then taken elsewhere.

But what if the hydrogen could be made on-site? It would cut down on costs and make the process simpler. On this episode of Purple Is the New Green, David Wolff, Nel Hydrogen’s Region Manager for the Eastern U.S. and Canada, said that scenario already is a reality.

“We have 18 Nel hydrogen generators deployed that were sold to a Ford engine assembly plant in Canada. This is at a massive Ford engine building plant,” he said. “These 18 hydrogen generators are serving to supply hydrogen for plasma spray of a cast iron-like lining on the inner cylinder bore of aluminum engine blocks.”

Those engines go in the Ford EcoBoost engine used in the F-150, North America’s best-selling vehicle family. “We’re very proud of that use of our hydrogen generators,” Wolff said.

It’s a great example of creating the hydrogen on-site when needed rather than having to deal with the drawbacks that can come with transportation. Yet, Wolff said too few people understand that having on-site hydrogen is an option.

“One of the challenges for … Nel over the years in the industrial world has been making people aware that on-site hydrogen was an alternative,” he said, comparing it to people getting milk delivered by a milkman. “You had to make people aware there were other ways to get your milk.

“In this case, it’s even better, because you can get your hydrogen and you can make it yourself.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

physician advisor
Navigating Payer Denials: A Physician Advisor’s Perspective #2
December 2, 2025

A physician advisor recently described a case that should unsettle anyone who cares about fair, clinically grounded coverage decisions: a Medicaid patient arrived comatose from an overdose, was emergently intubated, developed aspiration pneumonia, and stayed through three midnights before leaving against medical advice. By any bedside standard, this is acute, unstable care—exactly what…

Read More
Inside ERISA Denials: Why Employers May Be the Real Decision-Makers Behind Your Insurance Card
December 2, 2025

Insurance denials aren’t new, but they’re hitting a breaking point right now. As prior authorizations surge and patients face longer delays for everything from imaging to specialty drugs, more providers are realizing that the “payer” on the card often isn’t the one truly holding the reins. A growing share of Americans are covered…

Read More
Laying Out the Landscape in Today’s Patient Monitoring
Laying Out the Landscape in Today’s Patient Monitoring
December 2, 2025

More and more hospital environments rely on continuous, high-quality data to support faster clinical decisions, but much of today’s patient monitoring still varies widely by unit, device, and workflow. This episode kicks off a five-part Health and Life Sciences at the Edge series exploring The Future of Patient Monitoring. Intel’s Kaeli Tully, Solutions Engineer…

Read More
Culture
People-Centric HR in Practice: How Jen Schomer Turns Organizational Chaos into a Culture of Trust and Performance
December 2, 2025

In today’s whiplash workplace—where startups scale fast, funding dries up faster, and employee expectations keep evolving—HR isn’t a back-office function anymore. The rise of fractional leadership, remote teams, and constant regulatory change has forced companies to rethink how they support people while still hitting business goals. Leaders are realizing that “culture issues” often trace…

Read More